Investor Presentation for Q1 & FY''27

www.nureca.com Dated-21.07.2026 BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA Corporate Relations Department LIMITED Phiroze Jeejeebhoy Towers Listing Department Dalal Street, Fort Exchange Plaza, 5th Floor, Plot no. C/1 Mumbai-400001 G Block, Bandra Kurla Complex, Bandra (E) Scrip code: 543264 Mumbai-400051 Scrip Code: NURECA Subject: Investor Presentation (Q1&FY’27) Dear Sir/ Madam, In furtherance to the un-audited standalone and consolidated financial results of the Company already forwarded to the stock exchanges this day in compliance of Regulations 30, 33 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, also please find enclosed herewith Investor Presentation (Q1&FY’27) based on the financial performance of the Company for the quarter ended June 30, 2026. The above is for your information and records. Thanking you, Yours faithfully, For Nureca Limited (Nishu Kansal) Company Secretary & Compliance Officer M. No. A33372 NURECA LIMITED Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009 Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS, Andheri West, Mumbai – 400053 Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868 Investor Presentation Q1 & FY’27 Trusted for Life Building India’s leading consumer healthcare platform across brands, connected devices, omnichannel distribution and manufacturing. Disclaimer The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any investor should subscribe / purchase the company shares. The Company makes no representation or warranty, express or implied, as to, and does not accept any responsibility or liability with respect to, the fairness, accuracy, completeness or correctness of any information contained herein. This presentation may include certain “forward looking statements”. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties which could cause actual outcomes and results to differ materially from these statements. Important factors that could cause actual results to differ materially from our expectations include, amongst others, general economic and business conditions in India and abroad, ability to successfully implement our strategy, our research & development efforts, our growth & expansion plans and technological changes, changes in the Indian and international interest rates, change in laws and regulations that apply to the healthcare industry, increasing competition, changes in political conditions in India. Neither the company, nor its Directors and any of the affiliates or employee have any obligation to update or otherwise revise any forward-looking statements. The readers may use their own judgment and are advised to make their own calculations before deciding on any matter based on the information given herein. No part of this presentation may be reproduced, quoted or circulated without prior written approval from Nureca Ltd. Table of Contents 1 The Quarter at a Glance 2 Financial Performance 3 About our Business 4 Growth & Outlook The Quarter at a Glance Dear Shareholders, The operational turnaround we delivered in FY26 has carried into the new financial year. Our focus remains on profitable growth and disciplined cost management as we build out our consumer healthcare platform across healthcare, wellness and personal-care categories. Manufacturing will be central to our long-term strategy. The expansion of our capabilities in Punjab is intended to deepen supply-chain control and import substitution, while opening new opportunities in medical devices, healthcare consumables and hygiene products. Alongside this, Dr Trust 360 continues to strengthen our connected-health ecosystem, now with AI-powered health insights for our users. I thank our shareholders, employees, channel partners and customers for their continued trust. We remain committed to building a stronger, more efficient and innovation-led organisation that creates sustainable value for all stakeholders. Saurabh Goyal Chairman & Managing Director SECTION 1 · QUARTER AT A GLANCE Q1 FY'27 Highlights ₹ 40.3 Cr ₹ 51.8 Cr 38.8 % Revenue from Operations GMV Gross Margin ▲ 14% QoQ (Q4 FY 26: ₹35.4 Cr) · 18% YoY Q4 FY 26: ₹ 49.7 Cr 6 bps YoY ₹ 3.4 Cr ( 8.7% ) ₹ 4.43 Cr ( 10.5% ) ₹ 110 Cr Operating Profit / Margin Profit Before Tax Net Cash & Investments vs ₹2.5 Cr (7.2%) in Q4 FY 26 Reported PAT: ₹ 3.1 Cr Debt-free Your Company achieved its highest quarterly sales & Profitability in last 16 quarters, marking its strongest performance since Q4 FY 2021–22. Operating Profit → PBT Bridge (Q1 FY'27 Actuals) + ₹ 1.82 Cr − ₹ 0.20 Cr − ₹ 0.61 Cr ₹ 4.43 Cr Q1 FY'27 ₹ 3.42 Cr ₹ 4.43 Cr 10.5% of revenue Operating Profit PBT Other Income Finance Cost Depreciation (8.5% of revenue) (10.1% of revenue) Financial Performance P&L Summary (Consolidated) ₹ Crore Q1' FY 27 Q4' FY 26 QoQ % Q1' FY 26 YoY % Revenue from operations 40.3 35.4 14% 34.2 18% Other Income 1.8 1.0 80% 2.6 -31% Total Revenue 42.1 36.4 16% 36.8 14% Total Expenses 36.9 41.1 -10% 34.8 6% Operating Profits 3.5 2.6 35% -0.6 683% EBITDA 5.2 -4.7 211% 2.0 160% Finance Cost 0.2 0.3 -33% 0.2 0% Depreciation 0.6 0.4 50% 0.5 20% PBT 4.4 -5.4 181% 1.3 238% Current tax 0.2 1.8 -89% 0.1 100% Deferred tax 1.1 -1.2 192% 0.3 267% PAT 3.1 -6.0 152% 0.9 244% Total Comprehensive Income 3.1 -5.9 153% 0.9 244% EPS (in INR) 3.2 -6.45 150% 0.8 300% Gross Margin% 39% 40% -1% 35% 4% Operating Margin% 8.7% 7.3% 1.3% -1.8% 10.4% EBITDA% 12% -13% 25% 5% 7% PAT% 7.4% -16.5% 23.8% 2.4% 4.9% KPI Trends About our Business Nureca at a Glance A branded consumer healthcare platform Combining products, distribution, digital health and manufacturing Connected health Trusted consumer brands Omnichannel distribution Manufacturing-led growth ecosystem B D 360 M Expanding domestic Online marketplaces, quick Dr Trust and Dr Physio Dr Trust 360 linking smart production in medical commerce, across home healthcare and devices, health data and devices, healthcare direct-to-consumer and wellness personalised insights consumables and hygiene offline trade products From digital-first healthcare products to an integrated consumer healthcare platform Brand Range Role Key Product Categories Example Products Vital monitoring, chronic care devices, connected Dr Trust Point of Care Monitoring and diagnosis at home BP monitors, glucometers, pulse oximeters, thermometers, nebulizers health devices Everyday fitness, body tracking, and Body metrics, activity support, exercise and fitness Personal scales, body composition scales, smart scales, yoga and exercise accessories, fitness Dr Trust Fitness active wellness tools tracking products Massage-led pain relief, muscle Massage guns, foot massagers, neck massagers, back massagers, handheld and portable Dr Physio Massage Therapy relaxation, and recovery support massagers Dr Trust Therapy & Heat therapy, pain management, Heat therapy, rehab devices, recovery tools, pain Heating pads, hot water bags, TENS/EMS devices, rehab and mobility support devices Recovery rehabilitation, and recovery support management devices Passive support, posture, and comfort Bracing, support, ergonomic comfort, orthopedic Lumbar supports, knee supports, posture correctors, coccyx cushions, cervical pillows, Dr Trust Orthotics solutions aids orthopedic cushions, memory foam pillows Care, comfort, and wellness solutions Mother care, baby care, feeding support, baby Breast pumps, bottle sterilizers, baby thermometers, nasal aspirators, baby grooming kits, Trumom Mother & Baby for mothers and infants monitoring and comfort feeding and comfort products Wellness-ori [Showing first 8,000 characters — download PDF for full document]